|
Note 12 - Subsequent Events (Details) (USD $) In Millions, except Share data, unless otherwise specified
|
0 Months Ended |
9 Months Ended |
0 Months Ended |
12 Months Ended |
0 Months Ended |
|
Sep. 23, 2014
|
Sep. 17, 2014
|
Feb. 11, 2015
|
Dec. 31, 2014
|
Dec. 31, 2013
|
Dec. 31, 2012
|
Feb. 18, 2015
|
Feb. 18, 2015
|
| Note 12 - Subsequent Events (Details) [Line Items] |
|
|
|
|
|
|
|
|
| Stock Issued During Period, Shares, New Issues |
10,000,000 |
8,364,379 |
|
|
|
|
|
|
| Share Price (in Dollars per share) |
|
|
|
1.90 |
|
|
|
|
| Proceeds From Issuance of Common Stock Gross (in Dollars) |
$ 20.0 |
$ 16.6 |
|
|
|
|
|
|
| Preferred Stock, Shares Issued |
|
|
|
10,000 |
0 |
|
|
|
| Proceeds from Issuance or Sale of Equity (in Dollars) |
|
16.1 |
|
|
|
|
|
|
| Payments of Stock Issuance Costs (in Dollars) |
|
0.5 |
|
|
|
|
|
|
| Series B Convertible Preferred Stock [Member] | Convertible Preferred Stock [Member] | Subsequent Event [Member] | Exchange Agreement With Certain Affiliates of Biotechnology Value Fund [Member] |
|
|
|
|
|
|
|
|
| Note 12 - Subsequent Events (Details) [Line Items] |
|
|
|
|
|
|
|
|
| Stock Issued During Period, Shares, New Issues |
|
|
4,000 |
|
|
|
|
|
| Series B Convertible Preferred Stock [Member] | Convertible Preferred Stock [Member] | Subsequent Event [Member] |
|
|
|
|
|
|
|
|
| Note 12 - Subsequent Events (Details) [Line Items] |
|
|
|
|
|
|
|
|
| Preferred Stock, Shares Issued |
|
|
1,333 |
|
|
|
|
|
| Convertible Preferred Stock, Price Per Share (in Dollars per share) |
|
|
1,500 |
|
|
|
|
|
| Proceeds From Issuance of Convertible Preferred Stock Gross (in Dollars) |
|
|
2 |
|
|
|
|
|
| Convertible Preferred Stock to Be Converted |
|
|
1,000 |
|
|
|
|
|
| Maximum Ownership Percentage Of Common Shares Outstanding Post Conversion |
|
|
4.99% |
|
|
|
|
|
| Option Expiration Period |
|
|
30 days |
|
|
|
|
|
| Series B Convertible Preferred Stock [Member] | Subsequent Event [Member] | Exchange Agreement With Certain Affiliates of Biotechnology Value Fund [Member] |
|
|
|
|
|
|
|
|
| Note 12 - Subsequent Events (Details) [Line Items] |
|
|
|
|
|
|
|
|
| Stock Issued During Period, Shares, New Issues |
|
|
4,000 |
|
|
|
|
|
| Common Stock [Member] | Subsequent Event [Member] | Exchange Agreement With Certain Affiliates of Biotechnology Value Fund [Member] |
|
|
|
|
|
|
|
|
| Note 12 - Subsequent Events (Details) [Line Items] |
|
|
|
|
|
|
|
|
| Common Stock Exchanged for Shares of Convertible Preferred Stock |
|
|
4,000,000 |
|
|
|
|
|
| Common Stock [Member] | Subsequent Event [Member] |
|
|
|
|
|
|
|
|
| Note 12 - Subsequent Events (Details) [Line Items] |
|
|
|
|
|
|
|
|
| Stock Issued During Period, Shares, New Issues |
|
|
13,500,000 |
|
|
|
|
|
| Share Price (in Dollars per share) |
|
|
1.50 |
|
|
|
|
|
| Proceeds From Issuance of Common Stock Gross (in Dollars) |
|
|
20.0 |
|
|
|
|
|
| Common Stock [Member] |
|
|
|
|
|
|
|
|
| Note 12 - Subsequent Events (Details) [Line Items] |
|
|
|
|
|
|
|
|
| Stock Issued During Period, Shares, New Issues |
|
|
|
11,517,478 |
13,346,901 |
13,512,500 |
|
|
| Underwriter Options [Member] | Subsequent Event [Member] |
|
|
|
|
|
|
|
|
| Note 12 - Subsequent Events (Details) [Line Items] |
|
|
|
|
|
|
|
|
| Share Price (in Dollars per share) |
|
|
|
|
|
|
$ 1.50 |
$ 1.50 |
| Option Expiration Period |
|
|
30 days |
|
|
|
|
|
| Additional Shares Granted, Gross |
|
|
2,025,000 |
|
|
|
|
|
| Additional Shares Granted, Net |
|
|
|
|
|
|
1,199,660 |
|
| Proceeds from Issuance or Sale of Equity (in Dollars) |
|
|
|
|
|
|
1.7 |
|
| Subsequent Event [Member] |
|
|
|
|
|
|
|
|
| Note 12 - Subsequent Events (Details) [Line Items] |
|
|
|
|
|
|
|
|
| Proceeds from Issuance or Sale of Equity (in Dollars) |
|
|
|
|
|
|
|
22.4 |
| Proceeds From Issuance or Sale of Equity Gross (in Dollars) |
|
|
|
|
|
|
|
24.0 |
| Payments of Stock Issuance Costs (in Dollars) |
|
|
|
|
|
|
|
$ 1.6 |